| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.07B | 12.64B | 11.76B | 9.90B | 9.64B | 9.17B |
| Gross Profit | 9.02B | 7.82B | 6.52B | 5.66B | 5.20B | 5.02B |
| EBITDA | 6.63B | 6.64B | 6.08B | 4.92B | 3.46B | 7.13B |
| Net Income | 3.92B | 3.30B | 2.75B | 2.37B | 1.45B | 4.06B |
Balance Sheet | ||||||
| Total Assets | 179.18B | 136.89B | 139.43B | 136.08B | 194.34B | 193.50B |
| Cash, Cash Equivalents and Short-Term Investments | 2.38B | 3.62B | 1.37B | 2.11B | 7.95B | 607.00M |
| Total Debt | 20.98B | 20.28B | 20.70B | 22.91B | 18.38B | 14.17B |
| Total Liabilities | 149.62B | 107.90B | 111.71B | 110.30B | 171.58B | 170.75B |
| Stockholders Equity | 29.56B | 28.91B | 27.65B | 25.72B | 22.71B | 22.71B |
Cash Flow | ||||||
| Free Cash Flow | 4.56B | 4.29B | 4.20B | 3.05B | 3.07B | 2.67B |
| Operating Cash Flow | 5.02B | 4.66B | 4.61B | 3.54B | 3.55B | 3.12B |
| Investing Cash Flow | -3.52B | -4.25B | -921.00M | -8.80B | 677.00M | -786.00M |
| Financing Cash Flow | 32.30B | -6.33B | 79.00M | -64.34B | -1.84B | 62.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $37.77B | 19.07 | 24.63% | 1.06% | 10.61% | 53.46% | |
78 Outperform | $105.13B | 22.98 | 15.25% | 3.92% | 7.54% | 18.50% | |
77 Outperform | $85.78B | 15.78 | 13.57% | 1.19% | 14.25% | 42.14% | |
76 Outperform | $77.61B | 29.17 | 66.74% | 0.73% | 8.95% | 20.40% | |
75 Outperform | $50.90B | 23.18 | 15.91% | 1.07% | 5.79% | 50.79% | |
73 Outperform | $123.43B | 22.66 | 14.80% | 0.73% | 8.54% | 24.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |